Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial.
Amanda J WadeJ S DoyleE GaneC StedmanB DraperD IserS K RobertsW KempD PetrieN ScottP HiggsP A AgiusJ RoneyL StothersA J ThompsonM E HellardPublished in: Trials (2018)
ClinicalTrials.gov , ID: NCT02555475 . Registered on 15 September 2015.